Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
出版年份 2012 全文链接
标题
Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
作者
关键词
-
出版物
CELL CYCLE
Volume 11, Issue 18, Pages 3373-3379
出版商
Informa UK Limited
发表日期
2012-09-08
DOI
10.4161/cc.21397
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- YAP oncogene overexpression supercharges colon cancer proliferation
- (2012) Joseph Avruch et al. CELL CYCLE
- CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
- (2012) Claudia Capparelli et al. CELL CYCLE
- TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
- (2012) Makiko Fujii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways
- (2011) Harumi Kawaki et al. BONE
- A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions
- (2011) Chunling Yi et al. CANCER CELL
- LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
- (2011) H. Murakami et al. CANCER RESEARCH
- Mammalian Hippo pathway: from development to cancer and beyond
- (2011) Y. Bao et al. JOURNAL OF BIOCHEMISTRY
- A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription
- (2011) Y. Bao et al. JOURNAL OF BIOCHEMISTRY
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis
- (2011) Lin Ge et al. PLoS One
- YAP is a candidate oncogene for esophageal squamous cell carcinoma
- (2010) Tomoki Muramatsu et al. CARCINOGENESIS
- The Hippo in the room: A new look at a key pathway in cell growth and transformation
- (2010) Africa Fernandez-L et al. CELL CYCLE
- Transforming growth factor-beta 1 (TGF-β1)- and β2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer
- (2010) J. MAEDA et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- The Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-β-SMAD Pathway
- (2010) Xaralabos Varelas et al. DEVELOPMENTAL CELL
- Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
- (2009) B. Zhao et al. CANCER RESEARCH
- The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
- (2009) K. L. Bennewith et al. CANCER RESEARCH
- Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways
- (2009) Claudio Alarcón et al. CELL
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
- (2009) Heng Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- The TEAD/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathway
- (2008) Shian Wu et al. DEVELOPMENTAL CELL
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
- TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal
- (2008) Xaralabos Varelas et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation